RIM
ICPT

RS Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

RS Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7,016
Closed -$1.66M – 399
2014
Q3 		$1.66M Buy
7,016
+3,802
+118% +$969K 0.02% 340
2014
Q2 		$761K Sell
3,214
-36,047
-92% -$9.5M 0.01% 346
2014
Q1 		$12.9M Buy
+39,261
New +$13.2M 0.08% 216

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RS Investment Management's ICPT Position: Q4 2014 in Review

RS Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2014, closing a stake of 7,016 shares — an estimated $1.66M sold.

RS Investment Management first reported a position in ICPT in Q1 2014 and held it in 3 quarters. The position peaked at $12.9M in Q1 2014. 169 funds tracked by Wall St. Rank hold ICPT as of Q4 2014.

  • RS Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • RS Investment Management sold 7,016 Intercept Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.66M.
  • RS Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
  • RS Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $12.9M in Q1 2014.
  • 169 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2014.

Based on RS Investment Management's 13F filing for Q4 2014, filed 12 Feb 2015.